1. Home
  2. PGEN vs NEOG Comparison

PGEN vs NEOG Comparison

Compare PGEN & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$6.39

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Neogen Corporation

NEOG

Neogen Corporation

HOLD

Current Price

$12.03

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
NEOG
Founded
1998
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.6B
IPO Year
2013
1995

Fundamental Metrics

Financial Performance
Metric
PGEN
NEOG
Price
$6.39
$12.03
Analyst Decision
Buy
Buy
Analyst Count
4
4
Target Price
$13.65
★ $14.00
AVG Volume (30 Days)
★ 4.6M
4.2M
Earning Date
11-12-2026
10-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 99.20
EPS
★ 0.03
N/A
Revenue
$230,981,000.00
★ $870,400,000.00
Revenue This Year
$2,365.68
$1.73
Revenue Next Year
$85.75
N/A
P/E Ratio
$220.17
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$3.04
$5.37
52 Week High
$8.98
$14.26

Technical Indicators

Market Signals
Indicator
PGEN
NEOG
Relative Strength Index (RSI) 36.29 47.66
Support Level $6.08 $11.25
Resistance Level $7.44 $12.55
Average True Range (ATR) 0.44 0.69
MACD -0.17 -0.06
Stochastic Oscillator 2.37 39.08

Price Performance

Historical Comparison
PGEN
NEOG

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About NEOG Neogen Corporation

Neogen Corp is develop, manufacture and market a diverse line of products and services dedicated to food and animal safety. Its Food Safety segment consists mainly of diagnostic test kits and complementary products (e.g., culture media) sold to food and animal feed producers and processors to preserve the safety and quality of food to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. These products also ensure the general hygiene of the food manufacturing environment. It also have products to determine food quality and nutritional components. Its segments are Food, Animal safety. Majority of revenue comes from Food Safety. It has presence in United states, and International market.

Share on Social Networks: